2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

@article{Stone20142013AG,
  title={2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.},
  author={N. Stone and Jennifer G. Robinson and A. Lichtenstein and C. N. Bairey Merz and C. Blum and R. Eckel and A. Goldberg and David L. Gordon and D. Levy and D. Lloyd‐Jones and P. McBride and J. Schwartz and Susan T. Shero and Sidney C. Smith and K. Watson and P. Wilson and Karen M Eddleman and N. Jarrett and K. LaBresh and Lev Nevo and J. Wnek and Jeffrey L. Anderson and J. Halperin and N. Albert and B. Bozkurt and R. Brindis and L. Curtis and D. DeMets and J. Hochman and R. Kovacs and E. Ohman and S. Pressler and F. Sellke and W. Shen and G. Tomaselli},
  journal={Circulation},
  year={2014},
  volume={129 25 Suppl 2},
  pages={
          S1-45
        }
}
Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk S2 The goals of the … 
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
TLDR
The goals of the American College of Cardiology and the American Heart Association are to prevent cardiovascular diseases (CVDs) and improve the management of these diseases. Expand
2013 ACC/AHA guideline on the assessment of cardiovascular risk.
TLDR
Concerns are raised that the ACC/AHA Risk Assessment Work Group equations to estimate the risk of a first hard atherosclerotic cardiovascular event using data from broadly representative cohorts of the U.S. population may not adequately protect against adverse events. Expand
Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline.
The 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guideline recommended statins as first-line therapy, based on Class IA Evidence, to reduce cardiovascular riskExpand
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Preamble e346 1. Introduction e347 2. Overview of Acs e349 3. Initial Evaluation and Management e350 4. Early Hospital Care e359
LDL-cholesterol targets after the ACC/AHA 2013 guidelines: evidence that lower is better?
Approximately 25 years ago, the first Adult Treatment Panel (ATP) guidelines set the stage for low-density lipoprotein cholesterol (LDL-C) as both a risk factor and a target of therapy [(1)][1].Expand
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
TLDR
The ACC and AHA have collaborated with the National Heart, Lung, and Blood Institute and stakeholder and professional organizations to develop guidelines, standards, and policies that promote optimal patient care and cardiovascular health. Expand
2013 ACC/AHA Cholesterol Guideline for Reducing Cardiovascular Risk: What is so Controversial?
TLDR
In November 2013, the American College of Cardiology and American Heart Association released a clinical practice guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease (ASCVD) risk in adults, developed from a rigorous systematic review of randomized, controlled trials and meta-analyses that evaluated ASCVD outcomes. Expand
Preventing Atherosclerotic Cardiovascular Disease Using American College of Cardiology and American Heart Association Prevention Guidelines: Some Good News, But Caveats Remain
  • N. Stone
  • Medicine
  • Journal of the American Heart Association
  • 2016
TLDR
It is important to look carefully at papers that comment on the 2013 American College of Cardiology and American Heart Association cholesterol levels and risk to avoid being misled. Expand
Reply: Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease: A Cause for Concern, But a Few Words of Caution.
The 2013 American Heart Association/American College of Cardiology (ACC/AHA) Guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults [(1)][1]Expand
Trends in Lipid, Lipoproteins, and Statin Use Among U.S. Adults: Impact of 2013 Cholesterol Guidelines.
In 2013, the American College of Cardiology (ACC) and the American Heart Association (AHA) transitioned their recommendations for lipid management from an approach focused on “titration to goalExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 278 REFERENCES
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
TLDR
The goals of the American College of Cardiology and the American Heart Association are to prevent cardiovascular diseases (CVDs) and improve the management of these diseases. Expand
2013 ACC/AHA guideline on the assessment of cardiovascular risk.
TLDR
Concerns are raised that the ACC/AHA Risk Assessment Work Group equations to estimate the risk of a first hard atherosclerotic cardiovascular event using data from broadly representative cohorts of the U.S. population may not adequately protect against adverse events. Expand
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
TLDR
The medical profession should play a central role in evaluating the evidence related to drugs, according to a report by the World Health Organization and the European Medicines Agency. Expand
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
TLDR
The ACC and AHA have collaborated with the National Heart, Lung, and Blood Institute and stakeholder and professional organizations to develop guidelines, standards, and policies that promote optimal patient care and cardiovascular health. Expand
Asian Americans and cardiometabolic risk why and how to study them.
TLDR
An initiative to study Asian American groups with regard to their risk of diabetes and cardiovascular disease with the impetus stems from the increasing number of reported cases of diabetes in these groups. Expand
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
TLDR
This is a PDF file of an unedited manuscript that has been accepted for publication and will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Expand
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
TLDR
Harmon S. Jordan, ScD, Lev Nevo, MD, Janusz Wnek, PhD Jeffrey L. Anderson,MD, FACC, FAHA, Chair-Elect, Nancy M. Halperin, PhD. Expand
Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk.
TLDR
This is a PDF file of an unedited manuscript that has been accepted for publication and will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Expand
Heart Association Task Force on Practice Guidelines Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic
TLDR
This study presents a meta-analysis of 120 patients with a history of coronary artery disease over a 12-month period and finds no clear pattern in their LDL-cholesterol levels or Atherosclerotic disease. Expand
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)
TLDR
Treatment with pravastatin in women with elevated cholesterol but no history of cardiovascular disease provides a benefit similar to that seen in men, and this benefit is more marked in older women. Expand
...
1
2
3
4
5
...